Zura Bio Limited (ZURA)
NASDAQ: ZURA
· Real-Time Price · USD
2.10
-0.19 (-8.30%)
At close: Sep 25, 2025, 3:59 PM
2.10
0.00%
After-hours: Sep 25, 2025, 04:10 PM EDT
-8.30% (1D)
| Bid | 1.65 |
| Market Cap | 136.54M |
| Revenue (ttm) | 2K |
| Net Income (ttm) | -67.76M |
| EPS (ttm) | -0.74 |
| PE Ratio (ttm) | -2.84 |
| Forward PE | -2.64 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.68 |
| Volume | 285,956 |
| Avg. Volume (20D) | 636,233 |
| Open | 2.29 |
| Previous Close | 2.29 |
| Day's Range | 2.07 - 2.29 |
| 52-Week Range | 0.97 - 5.07 |
| Beta | -0.02 |
| Ex-Dividend Date | n/a |
About ZURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-10.07%
Zura Bio shares are trading lower after the compan...
Unlock content with
Pro Subscription
2 months ago · businesswire.com
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company developing novel dual-pathway anti...
